Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Merck & Company, Inc.
MRK
$105.26
Name : Merck & Company, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $262,916,669,440.00
EPSttm : 7.56
finviz dynamic chart for MRK
Merck & Company, Inc.
$105.26
0.75%
$0.8

Float Short %

1.5

Margin Of Safety %

10

Put/Call OI Ratio

0.69

EPS Next Q Diff

-0.81

EPS Last/This Y

1.32

EPS This/Next Y

-0.68

Price

105.29

Target Price

110.52

Analyst Recom

1.96

Performance Q

16.79

Relative Volume

0.55

Beta

0.3

Ticker: MRK




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-02MRK101.060.590.78739755
2025-12-03MRK102.320.600.57748445
2025-12-04MRK100.890.610.75754082
2025-12-05MRK99.720.610.55760107
2025-12-08MRK98.960.600.06742619
2025-12-09MRK96.860.600.96749676
2025-12-10MRK97.630.620.51767451
2025-12-11MRK99.040.620.29774678
2025-12-12MRK100.310.620.02782420
2025-12-15MRK100.180.700.42712196
2025-12-16MRK98.220.700.34719014
2025-12-17MRK99.350.700.48724261
2025-12-18MRK100.70.700.55728301
2025-12-19MRK101.070.700.29735837
2025-12-22MRK104.720.630.42625677
2025-12-23MRK105.050.620.31638181
2025-12-26MRK106.830.630.24657927
2025-12-29MRK106.650.630.54646251
2025-12-30MRK106.090.690.64627672
2025-12-31MRK105.280.690.92633978
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-02MRK101.0318.94827.78.97
2025-12-03MRK102.2718.95346.28.97
2025-12-04MRK100.8918.94683.48.97
2025-12-05MRK99.7218.94731.48.97
2025-12-08MRK98.9318.9- 8.97
2025-12-09MRK96.8918.94500.08.97
2025-12-10MRK97.6218.94998.68.97
2025-12-11MRK99.0418.95177.48.97
2025-12-12MRK100.3218.95145.58.97
2025-12-15MRK100.2618.94796.98.97
2025-12-16MRK100.2619.34295.28.97
2025-12-17MRK99.2119.35052.18.97
2025-12-18MRK100.7119.55198.98.97
2025-12-19MRK101.1019.44911.08.97
2025-12-22MRK104.6219.45693.88.97
2025-12-23MRK105.1519.44912.18.97
2025-12-26MRK106.8519.44554.28.97
2025-12-29MRK106.6619.44430.68.97
2025-12-30MRK106.0819.44330.78.97
2025-12-31MRK105.2919.44273.88.97
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-02MRK-0.63-1.291.11
2025-12-03MRK-0.63-1.291.11
2025-12-04MRK-0.63-1.291.11
2025-12-05MRK-0.63-1.291.11
2025-12-08MRK-0.63-1.221.11
2025-12-09MRK-0.63-1.221.11
2025-12-10MRK-0.63-1.221.29
2025-12-11MRK-0.63-1.221.29
2025-12-12MRK-0.63-1.221.29
2025-12-15MRK-0.63-1.231.29
2025-12-16MRK-0.63-1.231.29
2025-12-17MRK-0.63-1.231.29
2025-12-18MRK-0.63-1.231.29
2025-12-19MRK-0.63-1.231.29
2025-12-22MRK-0.63-1.321.29
2025-12-23MRK-0.63-1.321.29
2025-12-26MRK-0.63-1.321.50
2025-12-29MRK-0.63-1.311.50
2025-12-30MRK-0.63-1.311.50
2025-12-31MRK-0.63-1.311.50
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

2.58

Avg. EPS Est. Current Quarter

2.05

Avg. EPS Est. Next Quarter

1.77

Insider Transactions

-0.63

Institutional Transactions

-1.31

Beta

0.3

Average Sales Estimate Current Quarter

16185

Average Sales Estimate Next Quarter

15990

Fair Value

116.14

Quality Score

97

Growth Score

80

Sentiment Score

88

Actual DrawDown %

21.8

Max Drawdown 5-Year %

-43.4

Target Price

110.52

P/E

13.92

Forward P/E

12.58

PEG

1.26

P/S

4.09

P/B

5.05

P/Free Cash Flow

20.02

EPS

7.56

Average EPS Est. Cur. Y​

8.97

EPS Next Y. (Est.)

8.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.79

Relative Volume

0.55

Return on Equity vs Sector %

9.4

Return on Equity vs Industry %

-0.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

4273.8
Merck & Company, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 73000
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
stock quote shares MRK – Merck & Co., Inc. Stock Price stock today
news today MRK – Merck & Co., Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRK – Merck & Co., Inc. yahoo finance google finance
stock history MRK – Merck & Co., Inc. invest stock market
stock prices MRK premarket after hours
ticker MRK fair value insiders trading